Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions

por Dierssen, Mara, Fructuoso, Marta, Martínez de Lagrán, María, Perluigi, Marzia, Barone, Eugenio
Publicado 2020

Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome

por Martinez de Lagran, Maria, Elizalde‐Torrent, Aleix, Paredes, Roger, Clotet, Bonaventura, Dierssen, Mara
Publicado 2022

The X-linked splicing regulator MBNL3 has been co-opted to restrict placental growth in eutherians

por Spruce, Thomas, Plass, Mireya, Gohr, André, Ray, Debashish, Martínez de Lagrán, María, Rot, Gregor, Nóvoa, Ana, Burguera, Demian, Permanyer, Jon, Miret, Marta, Zheng, Hong, Swanson, Maurice S., Morris, Quaid, Mallo, Moises, Dierssen, Mara, Hughes, Timothy R., Pernaute, Barbara, Irimia, Manuel
Publicado 2022